Pain, analgesia, and sedation in critically ill patients, particularly those with acute respiratory distress syndrome, is complex. Existing parenteral therapies are associated with significant adverse effects, particularly with respect to hemodynamics and long-term cognitive dysfunction. Volatile anesthetics (e.g., isoflurane, sevoflurane) induce sedation at various levels, especially in difficult-to-sedate patients. A phase III trial is ongoing with possible publication before 2024. Beyond ICU sedation, other indications of interest have emerged with broader use, including treatment of refractory bronchospasm.
- Provider:Society of Critical Care Medicine
- Activity Link: https://congress2024.sccm.org/aaStatic.asp?SFP=VFJVUUtHWFdAMTU3NjlAQ29uZ3Jlc3MgRGlnaXRhbA
- Start Date: 2024-02-01 06:00:00
- End Date: 2024-02-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
ABA - 0.75 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
ABP - 0.75 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Critical Care Medicine, Pediatric Critical Care Medicine, Surgical Critical Care
Subscribe
Login
0 Comments
Oldest